HEADER BIOSYNTHETIC PROTEIN 14-DEC-17 6BVY TITLE SFTI-HFRW-4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRYPSIN INHIBITOR 1 HFRW-4; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HELIANTHUS ANNUUS; SOURCE 4 ORGANISM_COMMON: COMMON SUNFLOWER; SOURCE 5 ORGANISM_TAXID: 4232 KEYWDS MELANOCORTIN, CYCLIC PEPTIDE, GRAFTING, PHARMACOPHORE, BIOSYNTHETIC KEYWDS 2 PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR C.I.SCHROEDER,A.WHITE REVDAT 3 15-NOV-23 6BVY 1 REMARK LINK ATOM REVDAT 2 09-MAY-18 6BVY 1 JRNL REVDAT 1 18-APR-18 6BVY 0 JRNL AUTH T.DUREK,P.M.CROMM,A.M.WHITE,C.I.SCHROEDER,Q.KAAS,J.WEIDMANN, JRNL AUTH 2 A.AHMAD FUAAD,O.CHENEVAL,P.J.HARVEY,N.L.DALY,Y.ZHOU, JRNL AUTH 3 A.DELLSEN,T.OSTERLUND,N.LARSSON,L.KNERR,U.BAUER,H.KESSLER, JRNL AUTH 4 M.CAI,V.J.HRUBY,A.T.PLOWRIGHT,D.J.CRAIK JRNL TITL DEVELOPMENT OF NOVEL MELANOCORTIN RECEPTOR AGONISTS BASED ON JRNL TITL 2 THE CYCLIC PEPTIDE FRAMEWORK OF SUNFLOWER TRYPSIN JRNL TITL 3 INHIBITOR-1. JRNL REF J. MED. CHEM. V. 61 3674 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29605997 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00170 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BVY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-DEC-17. REMARK 100 THE DEPOSITION ID IS D_1000231698. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : 1 PA REMARK 210 SAMPLE CONTENTS : 1 MM SFTI-HFRW-4, 90% H2O/10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-13C HSQC; 2D 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CCPNMR, TOPSPIN, CYANA REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30383 RELATED DB: BMRB REMARK 900 SFTI-HFRW-4 DBREF 6BVY A 1 14 PDB 6BVY 6BVY 1 14 SEQRES 1 A 14 CYS THR ALA SER ILE PRO PRO ILE CYS E9V DPN MMO TRP SEQRES 2 A 14 ARG HET E9V A 10 20 HET DPN A 11 20 HET MMO A 12 27 HETNAM E9V N-METHYL-L-HISTIDINE HETNAM DPN D-PHENYLALANINE HETNAM MMO N~2~-METHYL-L-ARGININE FORMUL 1 E9V C7 H11 N3 O2 FORMUL 1 DPN C9 H11 N O2 FORMUL 1 MMO C7 H16 N4 O2 SSBOND 1 CYS A 1 CYS A 9 1555 1555 2.11 LINK N CYS A 1 C ARG A 14 1555 1555 1.34 LINK C CYS A 9 N E9V A 10 1555 1555 1.33 LINK C E9V A 10 N DPN A 11 1555 1555 1.33 LINK C DPN A 11 N MMO A 12 1555 1555 1.33 LINK C MMO A 12 N TRP A 13 1555 1555 1.33 CISPEP 1 ILE A 5 PRO A 6 1 -0.11 CISPEP 2 ILE A 5 PRO A 6 2 -0.24 CISPEP 3 ILE A 5 PRO A 6 3 -0.13 CISPEP 4 ILE A 5 PRO A 6 4 -0.22 CISPEP 5 ILE A 5 PRO A 6 5 -0.19 CISPEP 6 ILE A 5 PRO A 6 6 -0.11 CISPEP 7 ILE A 5 PRO A 6 7 -0.17 CISPEP 8 ILE A 5 PRO A 6 8 -0.16 CISPEP 9 ILE A 5 PRO A 6 9 -0.31 CISPEP 10 ILE A 5 PRO A 6 10 -0.13 CISPEP 11 ILE A 5 PRO A 6 11 0.00 CISPEP 12 ILE A 5 PRO A 6 12 -0.20 CISPEP 13 ILE A 5 PRO A 6 13 -0.16 CISPEP 14 ILE A 5 PRO A 6 14 -0.16 CISPEP 15 ILE A 5 PRO A 6 15 -0.17 CISPEP 16 ILE A 5 PRO A 6 16 -0.13 CISPEP 17 ILE A 5 PRO A 6 17 -0.13 CISPEP 18 ILE A 5 PRO A 6 18 -0.09 CISPEP 19 ILE A 5 PRO A 6 19 -0.02 CISPEP 20 ILE A 5 PRO A 6 20 -0.20 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1